Abstract
This study sought to evaluate the use of serum eosinophil-derived neurotoxin (EDN), which has been proposed as a marker of airway inflammation in asthma in the diagnosis and evaluation of the severity and bronchial hyperresponsiveness in childhood asthma. We studied 72 children with atopic asthma, 36 children with nonatopic asthma, and 43 healthy controls. Skin prick tests, pulmonary function tests, and methacholine challenge tests were performed, in addition to total eosinophil count, serum ECP, and EDN being measured in all subjects. EDN levels were significantly higher in the atopic asthma group than those in the nonatopic asthma group or control group (p < 0.001), as were ECP levels (p < 0.001). EDN levels differed more significantly among groups divided by asthma severity (p < 0.001) than did ECP levels for these groups (p < 0.05). For the groups divided according to bronchial hyperresponsiveness, both EDN and ECP levels were significantly different (p < 0.005 and p < 0.01, respectively). Significant correlations were found between EDN and PC20 (γ = −0.281; p < 0.001), between ECP and PC20 (γ = −0.274; p < 0.005), and between EDN and ECP (γ = 0.443; p < 0.001). In conclusion, serum EDN, as another marker of eosinophilic inflammation together with ECP, may aid in the diagnosis of asthma, especially atopic asthma, and in the evaluation of the severity and bronchial hyperresponsiveness in childhood asthma.
Similar content being viewed by others
References
American Thoracic Society (2000) Guidelines for Methacholine and Exercise Challenge Testing-1999. Am J Respir Crit Care Med 161:309–329
Bacharier LB, Strunk RC, Mauger D, et al. (2004) Classifying asthma severity in children mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 170:426–432
Backman A (1994) Skin tests for epidemiologic studies. Allergy 49:493–494
Bousquet J, Chanez P, Lacoste JY, et al. (1990) Eosinophilic inflammation in asthma. N Engl J Med 323:1033–1039
Brown WG, Halonen MJ, Kaltenborn WT, Barbee RA (1979) The relationship of respiratory allergy, skin test reactivity, and serum IgE in a community population sample. J Allergy Clin Immunol 63:328–335
Ferguson AC, Vaughan R, Brown H, Curtis C (1995) Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. J Allergy Clin Immunol 95:23–28
Fujisawa T, Terada A, Atsuta J, et al. (1998) Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma. Clin Exp Allergy 28:19–25
Gleich GJ (2000) Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105:651–663
Global Initiative for Asthma (GINA) (1995) Global strategy for asthma management and prevention, updated 2002, 2004, 2005. Washington, DC: National Institutes of Health, NIH Publication No. 02-3659. Available at http://www.ginasthma.org (accessed 10 March 2006)
Gruber W, Eber E, Pfleger A, et al. (1999) Serum eosinophil cationic protein and bronchial responsiveness in pediatric and adolescent asthma patients. Chest 116:301–305
Hohlfeld JM, Schmiedl A, Erpenbeck VJ, Venge P, Krug N (2004) Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma. J Allergy Clin Immunol 113:496–502
Joseph-Bowen J, Klerk N, Holt PG, Sly PD (2004) Relationship of asthma, atopy, and bronchial responsiveness to serum eosinophil cationic proteins in early childhood. J Allergy Clin Immunol 114:1040–1045
Lonnkvist K, Hellman C, Lundahl J, et al. (2001) Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. J Allergy Clin Immunol 107:812–817
Lowhagen O, Wever AMJ, Lusuardi M, et al. (2002) The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients. Respir Med 96:95–101
Martinez FD (1999) Present and future treatment of asthma in infants and young children. J Allergy Clin Immunol 104:169–174
Morioka J, Kurosawa M, Inamura H, et al. (2000) Development of a novel enzyme-linked immunosorbent assay for blood and urinary eosinophil-derived neurotoxin: a preliminary study in patients with bronchial asthma. Int Arch Allergy Immunol 122:49–57
Niimi A, Amitani R, Suzuki K, et al. (1998) Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy 28:233–240
Park JW, Kim CW, Hong CS (1997) Clinical significance of eosinophil cationic protein (ECP) in bronchial asthma. J Korean Soc Allergol 17:260–269
Park Y, Kang H, Kang EK, Koh YY (2002) Blood eosinophil and serum eosinophil cationic protein as a marker of bronchial hyperresponsiveness in children with suspected asthma. J Korean Pediatr Soc 45:1577–1584
Plager DA, Adolphson CR, Gleich GJ (2001) A novel human homolog of eosinophil major basic protein. Immunol Rev 179:192–202
Prehn A, Seger RA, Faber J, et al. (1998) The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma. Pediatr Allergy Immunol 9:197–203
Rao R, Frederick JM, Enander I, et al. (1996) Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma. Clin Exp Allergy 26:789–793
Remes S, Korppi M, Remes K, et al. (1998) Serum eosinophil cationic protein (ECP) and eosinophil protein X (EPX) in childhood asthma: the influence of atopy. Pediatr Pulmonol 25:167–174
Sedgwick JB, Vrtis RF, Jansen KJ, et al. (2004) Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol 114:568–574
Sorkness C, McGill K, Busse WW (2002) Evaluation of serum eosinophil cationic protein as a predictive marker for asthma exacerbation in patients with persistent disease. Clin Exp Allergy 32:1355–1359
Vanto T, Koskinen P (1998) Serum eosinophil cationic protein in the evaluation of asthma severity in children. Allergy 53:415–419
Vatrella A, Ponticiello A, Parrella R, et al. (1996) Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma. Allergy 51:547–555
Wolthers OD (2003) Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma. Pediatr Allergy Immunol 14:248–254
Yoon KA, Lim HS, Kim H, Koh YY (1993) normal predicted values of pulmonary function test in Korean school-aged children. J Korean Pediatr Soc 36:25–37
Zimmerman B, Lanner A, Enander I, et al. (1993) Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 23:564–570
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, K.W., Lee, K.E., Kim, E.S. et al. Serum Eosinophil-Derived Neurotoxin (EDN) in Diagnosis and Evaluation of Severity and Bronchial Hyperresponsiveness in Childhood Asthma. Lung 185, 97–103 (2007). https://doi.org/10.1007/s00408-006-0054-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-006-0054-8